
Venture capital
Sound Bioventures
Sound Bioventures is a Scandinavian venture capital fund backing private biotech companies that are nearing or in clinical stage, in Europe and the USA, to develop novel medicines.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Sound Bioventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (ESMA register).
Latest investments
BetaRounds Sound Bioventures joined, from press and the firm’s own posts.
4 rounds in the last 12 months
Round sizes, Sound Bioventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Sound Bioventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Sound Bioventures
Events where Sound Bioventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Sound Bioventures is based in Sweden. It also has an office in Malmö.
3 fund vehicles are on public registers (ESMA register), including Sound Bioventures Fund I (D) AB, Sound Bioventures Fund I AB and Sound Bioventures Fund II AB.
Sectors: Biotech, Life sciences. From the firm’s own website.
Sound Bioventures lists 12 portfolio companies on its website, including Aboleris, Altay Therapeutics, AnaCardio, Artax Biopharma and Arthex.
Firms whose websites list some of the same companies include BioGeneration Ventures, Columbus Venture Partners and HealthCap.
Know before Sound Bioventures’s next round is announced.
PRO tracks Sound Bioventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.